Postchallenge hyperglycaemic spike associate with arterial stiffness

International Journal of Clinical Practice

Volumn 61, Issue 3, 2007, Pages 397-402

  Huang, C L ^a   Chen, M F ^a   Jeng, J S ^a   Lin, L Y ^a   Wang, W L ^a   Feng, M H ^a   Liau, C S ^a   Hwang, B S ^a   Lee, Y T ^a   Su, T C ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Arterial stiffness; Cardio ankle vascular index; Diabetes mellitus; Postchallenge hyperglycaemic spike; Pulse wave velocity

Indexed keywords

GLUCOSE;

ADULT; AGE DISTRIBUTION; ANALYTICAL PARAMETERS; AREA UNDER THE CURVE; ARTERY COMPLIANCE; ARTICLE; CARDIOANKLE VASCULAR INDEX; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE ASSOCIATION; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HYPERGLYCEMIA; MALE; MEASUREMENT; MULTIPLE LINEAR REGRESSION ANALYSIS; OBSERVER VARIATION; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RELIABILITY; REPEAT PROCEDURE; RIGIDITY; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

ADULT; ARTERIES; BLOOD GLUCOSE; BLOOD PRESSURE; COMPLIANCE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; VASCULAR RESISTANCE;

EID: 33847062472     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2006.01227.x     Document Type: Article

References (30)

1. Laakso M. Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes 1999; 48: 937-42.
2. Stamler J, Vaccaro O, Neaton J, Wentworth D. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434-44.
3. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis of Diagnostic criteria in Europe. Lancet 1999; 354: 617-21.
4. Temelkova-Kurktschiev TS, Koehler C, Henkel E, Leonhardt W, Fuecker K, Hanefeld M. Postchallenge plasma glucose and glycemic spike are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. Diabetes Care 2000; 23: 1830-4.
5. Hanefeld M, Koehler C, Henkel E, Fuecker K, Schaper F, Temelkova-Kurktschiev T. Post-challenge hyperglycemia relates more strongly than fasting hyperglycaemia with carotid intima- media thickness: the RIAD Study. Diabet Med 2000; 17: 835-40.
6. Qiao Q, Tuomilehto J, Borch-Johnsen K. Post-challenge hyperglycemia is associated with premature death and macrovascular complications. Diabetologia 2003; 46 (Suppl. 1): M17-21.
7. Westerhof N, O'Rourke MF. Haemodynamic basis for the development of left ventricular failure in systolic hypertension and for its logical therapy. J Hypertens 1995; 13: 943-52.
8. Yambe T, Yoshizawa M, Saijo Y et al. Brachio-ankle pulse wave velocity and cardio-ankle vascular index (CAVI). Biomed Pharmacother 2004; 58 (Suppl. 1): S95-8.
9. Fleiss JL. Repeated measurements studies. The Design and Analysis of Clinical Experiments, Chapter 8. New York: John Wiley & Sons, 1986: 220-40.
10. Role of cardiovascular risk factors in prevention and treatment of macrovascular disease in diabetes. American Diabetes Association. Diabetes Care 1989; 12: 573-9.
11. van Popele NM, Grobbee DE, Bots ML et al. Association between arterial stiffness and atherosclerosis: the Rotterdam study. Stroke 2001; 32: 454-60.
12. London GM, Guerin AP. Influence of arterial pulse and reflected waves on blood pressure and cardiac function. Am Heart J 1999; 138 (3 pt 2): 220-4.
13. Grundy SM, Benjamin IJ, Burke GL et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 1999; 100: 1134-46.
14. de Vegt F, Dekker JM, Ruhe HG et al. Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn study. Diabetologia 1999; 42: 926-31.
15. Skott P, Vaag A, Hother-Nielsen O et al. Effects of hyperglycemia on kidney function, atrial natriuretic factor and plasma rennin in patients with insulin-dependent diabetes mellitus. Scand J Clin Lab Invest 1991; 51: 715-27.
16. Grunwald JE, Brucker AJ, Schwartz SS et al. Diabetic glycemic control and retinal blood flow. Diabetes 1990; 39: 602-7.
17. Ceriello A. The possible role of postprandial hyperglycemia in the pathogenesis of diabetic complications. Diabetologia 2003; 46 (Suppl. 1): M9-16.
18. Ceriello A. Postprandial hyperglycemia and diabetes complications: is it time to treat? Diabetes 2005; 54: 1-7.
19. Chiasson JL, Josse RG, Gomis R et al. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomized trial. Lancet 2002; 359: 2072-7.
20. Chiasson JL, Josse RG, Gomis R et al. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA 2003; 290: 486-94.
21. Hanefeld M, Chiasson JL, Koehler C, Henkel E, Schaper F, Temelkova- Kurktschiev T. Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance. Stroke 2004; 35: 1073-8.
22. Shirakawa M. Estimation of organic atherosclerosis by pulse wave velocity (in Japanese). Tokyo Jikeikai Med J 1974; 89: 62-77.
23. Farrar DJ, Green HD, Bond MG, Wagner WD, Gobbee RA. Aortic pulse wave velocity, elasticity and composition in a nonhuman primate model of atherosclerosis. Circ Res 1978; 43: 52-62.
24. Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation 2002; 106: 2085-90.
25. Sutton-Tyrrell K, Najjar SS, Boudreau RM et al. Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation 2005; 111: 3384-90.
26. Yamashina A, Tomiyama H, Takeda K et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002; 25: 359-64.
27. Yamashina A, Tomiyama H, Arai T et al. Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk. Hypertens Res 2003; 26: 615-22.
28. Imanishi R, Seto S, Toda G et al. High brachial-ankle pulse wave velocity is an independent predictor of the presence of coronary artery disease in men. Hypertens Res 2004; 27: 71-8.
29. Wakabayashi I, Masuda H. Association of acute-phase reactants with arterial stiffness in patient with type 2 diabetes mellitus. Clin Chim Acta 2006; 365: 230-5.
30. Yambe T, Meng X, Hou X et al. Cardio-ankle vascular index (CAVI) for the monitoring of the atherosclerosis after heart transplantation. Biomed Pharmacother 2005; 59: S177-9.